Bruce Daugherty

Title: Bruce Daugherty: Innovator in Pharmaceutical Chemistry

Introduction

Bruce Daugherty is a notable inventor based in Mendham, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on Isometheptene isomers. His innovative approach has led to advancements in treatments for various neurovascular conditions.

Latest Patents

Daugherty holds a patent for a purified Isometheptene compound, which is characterized by its unique structure. This invention relates to the synthesis, purification, and characterization of an Isometheptene isomer mucate crystal, specifically the (R)-enantiomer. The (R)-Isometheptene enantiomer is recognized for its selective activity as a ligand for Imidazoline subtype 1 (I1) receptor sites. This compound is particularly promising as an antihypertensive agent, showing effectiveness in treating migraine and other neurogenic pain with fewer side effects compared to its racemate form.

Career Highlights

Daugherty is associated with Tonix Pharma Holdings Limited, a company based in Bermuda. His work has focused on developing pharmaceutical compositions that leverage the unique properties of the (R)-Isometheptene enantiomer. This innovative approach aims to provide effective treatment options for episodic tension-type headaches (ETTH) and related conditions.

Collaborations

Throughout his career, Daugherty has collaborated with notable colleagues, including Seth Lederman and Leland J Gershell. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Bruce Daugherty's contributions to the field of pharmaceutical chemistry, particularly through his patent on Isometheptene isomers, highlight his role as an innovator in developing effective treatments for neurovascular conditions. His work continues to influence the landscape of pharmaceutical research and development.